AAP
CSLT

Arax Advisory Partners’s CASTLIGHT HEALTH, INC. CSLT Stock Holding History

Arax Advisory Partners’s Portfolio CSLT Stock Details CSLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-582
Closed -$2K – 629
2018
Q3 		$2K Buy
+582
New +$2.06K ﹤0.01% 588

Other funds holding CSLT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
OMC
Oak Management Corp Wilton, Connecticut $3.24M AUM 83.68% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
CPA
Cowen Prime Advisors New York $290M AUM 57.8% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Arax Advisory Partners's CSLT Position: Q4 2018 in Review

Arax Advisory Partners sold out of CASTLIGHT HEALTH, INC. (CSLT) in Q4 2018, closing a stake of 582 shares — an estimated $2K sold.

Arax Advisory Partners first reported a position in CSLT in Q3 2018 and held it in 1 quarter. The position peaked at $2K in Q3 2018. 105 funds tracked by Wall St. Rank hold CSLT as of Q4 2018.

  • Arax Advisory Partners reported no remaining CASTLIGHT HEALTH, INC. position as of Q4 2018 after selling out during the quarter.
  • Arax Advisory Partners sold 582 CASTLIGHT HEALTH, INC. shares in Q4 2018, an estimated $2K.
  • Arax Advisory Partners first reported a position in CASTLIGHT HEALTH, INC. in Q3 2018 and held it in 1 quarter.
  • Arax Advisory Partners's CASTLIGHT HEALTH, INC. position peaked at $2K in Q3 2018.
  • 105 funds tracked by Wall St. Rank held CASTLIGHT HEALTH, INC. as of Q4 2018.

Based on Arax Advisory Partners's 13F filing for Q4 2018, filed 6 Feb 2019.